CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 263,962 shares at an average $20.70 ($5,464,611)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Planned sale Director sold 84,355 shares at an average $20.10 ($1,695,689)
- 4 Planned sale Chief Medical Officer sold 887 shares at $18.33 ($16,259)
- 4 Planned sale Chief Commercial Officer sold 145 shares at $18.33 ($2,658)
- 4 Planned sale CEO & President sold 2,683 shares at $18.33 ($49,179)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · New debt or obligation
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 40 · 796 filings